Mixed T-lymphocyte chimerism after allogeneic hematopoietic transplantation is predictive for relapse of AML/MDS

Chimerism testing following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) represents a promising tool for predicting disease relapse, although its precise role in this setting remains unclear. We inves...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Blood Marrow Transplant
Autori principali: Lee, Hans C., Saliba, Rima M., Rondon, Gabriela, Chen, Julianne, Charafeddine, Yasmeen, Medeiros, L. Jeffrey, Alatrash, Gheath, Andersson, Borje S., Popat, Uday, Kebriaei, Partow, Ciurea, Stefan, Oran, Betul, Shpall, Elizabeth, Champlin, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2015
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4604040/
https://ncbi.nlm.nih.gov/pubmed/26183077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.07.005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi